» Articles » PMID: 15195147

Structural Basis for Distinct Ligand-binding and Targeting Properties of the Receptors DC-SIGN and DC-SIGNR

Overview
Date 2004 Jun 15
PMID 15195147
Citations 232
Authors
Affiliations
Soon will be listed here.
Abstract

Both the dendritic cell receptor DC-SIGN and the closely related endothelial cell receptor DC-SIGNR bind human immunodeficiency virus and enhance infection. However, biochemical and structural comparison of these receptors now reveals that they have very different physiological functions. By screening an extensive glycan array, we demonstrated that DC-SIGN and DC-SIGNR have distinct ligand-binding properties. Our structural and mutagenesis data explain how both receptors bind high-mannose oligosaccharides on enveloped viruses and why only DC-SIGN binds blood group antigens, including those present on microorganisms. DC-SIGN mediates endocytosis, trafficking as a recycling receptor and releasing ligand at endosomal pH, whereas DC-SIGNR does not release ligand at low pH or mediate endocytosis. Thus, whereas DC-SIGN has dual ligand-binding properties and functions both in adhesion and in endocytosis of pathogens, DC-SIGNR binds a restricted set of ligands and has only the properties of an adhesion receptor.

Citing Articles

Glycan-Silica Nanoparticles as Effective Inhibitors for Blocking Virus Infection.

Perez-Alonso C, Lasala F, Rodriguez-Perez L, Delgado R, Rojo J, Ramos-Soriano J ACS Appl Mater Interfaces. 2025; 17(7):10292-10304.

PMID: 39908032 PMC: 11881045. DOI: 10.1021/acsami.4c15918.


Limitations of a proper SFTSV mouse model using human C-type lectin receptors.

Kim Y, Ro H, Lee J, Song Y, Lee H, Cho N Front Microbiol. 2025; 15:1452739.

PMID: 39749135 PMC: 11693710. DOI: 10.3389/fmicb.2024.1452739.


From viral assembly to host interaction: AFM's contributions to virology.

Ray A, Simpson J, Demir I, Gisbert V, Gomes D, Amadei F J Virol. 2024; 99(1):e0087324.

PMID: 39655953 PMC: 11784315. DOI: 10.1128/jvi.00873-24.


Synthesis of a multivalent α-1,2-mannobiose ligand for targeting C-type lectins.

Langer J, Hartmann L, Snyder N RSC Adv. 2024; 14(51):37950-37959.

PMID: 39610811 PMC: 11603336. DOI: 10.1039/d4ra06526c.


Controllable Enzymatic Synthesis of Natural Asymmetric Human Milk Oligosaccharides.

Tseng H, Tseng H, Ooi K, You C, Wang H, Kuo W JACS Au. 2024; 4(11):4496-4506.

PMID: 39610756 PMC: 11600167. DOI: 10.1021/jacsau.4c00830.